(+)-Thalidomide,
D-Thalidomide,
(R)-Thalidomide,
(R)-(+)-thalidomide,
R-(+)-Thalidomide,
2614-06-4,
NSC 91729,
UNII-QN61H68KLK,
QN61H68KLK,
CHEBI:61917,
Phthalimide, N-(2,6-dioxo-3-piperidyl)-, (+)-,
Phthalimide, N-(2,6-dioxo-3-piperidyl)-, D-(+)-,
2-[(3R)-2,6-dioxopiperidin-3-yl]-1H-isoindole-1,3(2H)-dione,
1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-, (R)-,
2-[(3~{R})-2,6-bis(oxidanylidene)piperidin-3-yl]isoindole-1,3-dione,
R-Thalidomide,
Thalidomide, (R)-,
(R)-(D)-Thalidomide,
AC1L2PIY,
AC1Q6NYI,
AC1Q6EZ6,
SCHEMBL41641,
BIDD:ER0498,
CHEMBL558551,
DTXSID6046971,
BDBM65362,
CTK8F2016,
ZINC1530948,
CCG-36381,
AJ-26715,
CJ-05221,
CJ-24062,
LS-109464,
(+)-Thalidomide, >=98% (HPLC), powder,
FT-0602275,
J-016277,
(R)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione,
2-[(3R)-2,6-dioxopiperidin-3-yl]isoindole-1,3-dione,
UNII-4Z8R6ORS6L component UEJJHQNACJXSKW-SECBINFHSA-N,
R-(+)-2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione,
(R)-(+)-2-(2,6-Dioxo-3-piperidinyl)-1H-iso-indole-1,3(2H)-dione,
2-[(3R)-2,6-dioxopiperidin-3-yl]-2,3-dihydro-1H-isoindole-1,3-dione,
6EL,
thalidomide,
CID75792,
AR-1I7055,
A4216,
50-35-1,
2768-12-9,